Linli Zhou

Linli Zhou

Auto-generated profile, based on publicly available information

Linli Zhou

Division of Pharmaceutical Science, University of Cincinnati College of Pharmacy, Cincinnati, OH, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Cancer Research
Verified
Journal Article
Closed access
PDF file
TLTianyi Liu
Tianyi Liu
LZLinli Zhou
Linli Zhou
YXYao Xiao
Yao Xiao
TAThomas Andl
Thomas Andl
YZYuhang Zhang
Yuhang Zhang
The tumor stroma and its cellular components are known to play an important role in tumor response to treatment. Here, we report a novel resistance mechanism in melanoma that is elicited by BRAF inhibitor (BRAFi)–induced noncanonical activation of nuclear β-catenin signaling in cancer-associated fibroblasts (CAF). Treatment with BRAFi leads to an expanded CAF population with increased β-catenin nuclear accumulation and enhanced biological properties. This CAF subpopulation is essential for melanoma cells to proliferate and acquire resistance to BRAFi/MEK inhibitors (MEKi). Mechanistically, BRAFi induces BRAF-CRAF heterodimerization and subsequent activation of ERK signaling in CAFs, leading to inactivation of the β-catenin destruction complex. RNA-seq identified periostin (POSTN) as a major downstream effector of β-catenin in CAFs. POSTN compensates for the loss of β-catenin in CAFs and mediates melanoma cell BRAFi/MEKi resistance. In melanoma cells, POSTN activates phosphoinositide 3-kinase (PI3K)/AKT signaling and subsequently reactivates the ERK pathway that was inhibited by BRAFi/MEKi. Collectively, these data underscore the role of BRAFi-induced CAF reprogramming in matrix remodeling and therapeutic escape of melanoma cells. Significance: β-Catenin activation in cancer-associated fibroblasts in response to BRAF inhibitors stimulates POSTN secretion to promote resistance in cancer cells, revealing POSTN as a potential matrix target in cancer therapy.

26 October 2021 in Therapeutic Innovation & Regulatory Science
Verified
Journal Article
Closed access
PDF file
XZXingxing Zheng
Xingxing Zheng
JSJingjing Shao
Jingjing Shao
LZLinli Zhou
Linli Zhou
LWLi Wang
Li Wang
YGYaqiong Ge
Yaqiong Ge
FFFeng Feng
Feng Feng

23 July 2025 in bioRxiv
Verified
Preprint
Open access
JWJie Wang
Jie Wang
BSBruna da Silva Soley
Bruna da Silva Soley
YXYao Xiao
Yao Xiao
LSLindsey G. Siegfried
Lindsey G. Siegfried
LZLinli Zhou
Linli Zhou
YZYuhang Zhang
Yuhang Zhang
SUMMARY: Cancer-associated fibroblasts (CAFs) exhibit striking plasticity, enabling them to adapt to external cues such as therapeutic and mechanical stress in the tumor microenvironment (TME). Here, we uncover a shared mechanotransduction pathway through which both BRAF inhibition and matrix stiffness converge in nuclear remodeling to drive CAF activation. Mechanistically, BRAF inhibitors (BRAFis) accelerate RAS-dependent RAF homo and heterodimerization and ERK signaling, leading to GSK-3β inactivation and Rho kinase (ROCK) activation. In parallel, stiff substrates engage integrin receptors to directly activate ROCK signaling. Activation of ROCK induces actin stress fiber assembly, generating mechanical forces that deform the nucleus. In both contexts, nuclear reshaping promotes β-catenin translocation and actin polymerization through a feedback loop that continuously enforces CAF activation and promotes melanoma progression. Notably, pharmacological inhibition of ROCK activity blocks both BRAFi- and stiffness-induced nuclear remodeling and β-catenin accumulation, identifying the ROCK–cytoskeleton–nucleus axis as a critical regulator of CAF adaptation and functionality. Collectively, these findings reveal a mechanically tuned nuclear signaling hub that integrates chemical and physical cues to promote stromal adaptation and suggest ROCK inhibition as a strategy to counteract therapy-induced fibroblast reprogramming and improve therapy response.

25 July 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
LSLindsey G. Siegfried
Lindsey G. Siegfried
LZLinli Zhou
Linli Zhou
JWJie Wang
Jie Wang
ACAutumn C. Campbell
Autumn C. Campbell
JHJennifer M. Hahn
Jennifer M. Hahn
YZYuhang Zhang
Yuhang Zhang
Tissue-engineered skin substitutes (TESS) represent a key therapeutic option for extensive cutaneous injuries when autologous grafting is limited; however, current constructs lack skin appendages, particularly hair follicles, resulting in incomplete functional and aesthetic restoration. A central barrier to engineering follicular structures within TESS is the rapid loss of hair-inductive features in cultured human dermal papilla (DP) fibroblasts and the difficulty of recreating epithelial-mesenchymal interactions required for early folliculogenesis. Here, we report a bioengineering platform that integrates self-organizing composite spheroids composed of adult human epidermal keratinocytes (KCs) and DP fibroblasts with laser-micropatterned collagen scaffolds to generate spatially defined hair peg-like structures within human TESS. Under optimized three-dimensional culture conditions, mixed KC-DP spheroids reproducibly undergo polarization, budding, and elongation to form hair peg-like structures that exhibit compartmentalized organization and expression of key follicle-associated markers. Transcriptomic analysis reveals activation of follicular-associated transcriptional programs in KCs, while DP fibroblasts retain DP-associated features under these conditions. When implanted into predefined microwells within collagen-based dermal scaffolds, these spheroids continue coordinated morphogenesis alongside epidermal stratification and dermal matrix formation, yielding engineered skin constructs containing spatially integrated hair peg-like structures. Although maturation into fully developed hair follicles remains to be achieved, this study establishes a scalable, clinically relevant platform for integrating early-stage follicular units into TESS. Collectively, these findings provide a foundation for future efforts toward appendage-inclusive skin regeneration using adult human cells. STATEMENT OF SIGNIFICANCE: Engineering human hair follicles in skin substitutes remains challenging because dermal papilla cells rapidly lose hair-inductive function during laboratory expansion, and existing organoid models are difficult to scale or integrate into engineered skin. Here, we present a laser-micropatterned collagen scaffold that spatially incorporates early-stage follicular units formed from human keratinocytes and dermal papilla cells. Through systematic optimization of cell state, spheroid configuration, culture conditions, and scaffold integration, mixed keratinocyte-dermal papilla cell spheroids reproducibly undergo polarization, budding, and elongation in 3D culture and retain hair peg-like organization after incorporation into micropatterned dermal scaffolds. This work advances hair follicle engineering toward clinically relevant skin constructs for studying human hair biology and regenerative skin therapies.

15 June 2026 in Cancer Research Communications
Verified
Journal Article
Open access
JWJie Wang
Jie Wang
BSBruna da Silva. Soley
Bruna da Silva. Soley
YXYao Xiao
Yao Xiao
LSLindsey G. Siegfried
Lindsey G. Siegfried
LZLinli Zhou
Linli Zhou
YZYuhang Zhang
Yuhang Zhang
Cancer-associated fibroblasts (CAFs) display remarkable plasticity, enabling them to adapt to therapeutic and mechanical stress within the tumor microenvironment (TME). Here, we identify a shared mechanotransduction pathway by which BRAF inhibition and matrix stiffness converge on ROCK-dependent cytoskeletal remodeling, nuclear deformation, and β-catenin nuclear accumulation in CAFs. Mechanistically, BRAF inhibitors (BRAFi) accelerate RAS-dependent RAF homo- and heterodimerization and promote ERK signaling, accompanied by GSK-3β inactivation and activation of the ROCK pathway. ROCK activation induces actin stress fiber assembly and nuclear deformation. Stiff substrates recapitulate BRAFi-induced actin remodeling and nuclear deformation in CAFs. In both contexts, nuclear remodeling is associated with β-catenin nuclear accumulation and CAF activation. Functionally, constitutive β-catenin activation in mouse fibroblasts enhanced CAF-like features in vitro and promoted melanoma growth and matrix remodeling in vivo. Pharmacological ROCK inhibition blocked both BRAFi- and stiffness-induced nuclear remodeling and β-catenin accumulation, identifying the ROCK–cytoskeleton–nucleus axis as a mediator of CAF responses to therapeutic and mechanical cues. Collectively, these findings reveal a mechanically tuned signaling mechanism that contributes to CAF activation, supporting ROCK inhibition as a potential strategy to limit tumor-promoting stromal adaptation during targeted therapy.

16 July 2026
Verified
Other
Open access
JWJie Wang
Jie Wang
BSBruna da Silva Soley
Bruna da Silva Soley
YXYao Xiao
Yao Xiao
LSLindsey G. Siegfried
Lindsey G. Siegfried
LZLinli Zhou
Linli Zhou
YZYuhang Zhang
Yuhang Zhang
Figure S15. ERK signaling is downstream of BRAFi-induced RAF activation